About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

RECRUITINGPhase 2NCT06466135

Study of WAL0921 in Patients With Glomerular Kidney Diseases

This is an adaptive prospective, multi-center, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy, pharmacokinetics, and pharmacodynamics of WAL0921 in subjects with g...

Lead sponsor: Walden Biosciences•2 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Michelle Skupien

CONTACT

8573141961 clinicaltrials@waldenbiosciences.com

Sponsors

Lead Sponsor

Walden Biosciences

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Adults, age 18-75 years
•Diagnosis of one of the following glomerular kidney diseases: diabetic nephropathy; primary focal segmental glomerulosclerosis; treatment resistant-minimal change disease; primary IgA nephropathy; primary membranous nephropathy
•eGFR greater than or equal to 30 mL/min/1.73 m2

Exclusion Criteria

•Currently pregnant or planning to become pregnant
•History of organ transplantation
•History of alcohol or substance use disorder
•Acute dialysis or acute kidney injury within 6 months of Screening
•Any prior or current medical condition that, in the judgment of the Investigator, would prevent the subject from safely participating in and/or completing all study requirements

Related studies

Interview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.

NCT05505500 · Fluid Overload, Glomerulosclerosis, Focal Segmental, and more

Recurrence Post-transplant Observational Study in Focal Segmental Glomerulosclerosis and Minimal Change Disease

NCT05650619 · Focal Segmental Glomerulosclerosis, Minimal Change Disease, and more

Effect of Acute Hypoxia on Renal Hemodynamic in Healthy Volunteers, Patients With Diabetes and Patients With Diabetes and Kidney Disease

NCT06846034 · Diabetes, Diabetic Kidney Disease, and more

RECRUITINGPhase 2/3

Clinical Outcome of Vinpocetine in Diabetic Nephropathy

NCT06441591 · Diabetic Kidney Disease, Diabetic Nephropathies

COMPLETEDPhase 1/2

Impact of Metabolic Surgery on Pancreatic, Renal and Cardiovascular Health in Youth With Type 2 Diabetes

NCT03620773 · Type 2 Diabetes Mellitus, Obesity, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 6, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE2

Enrollment96

Start dateJul 2024

Last updatedApr 6, 2025

Condition

Diabetic Nephropathies Primary Focal Segmental Glomerulosclerosis Minimal Change Disease Primary Immunoglobulin A Nephropathy Primary Membranous Nephropathy

Locations shown

Colorado Kidney and Vascular Care

Denver, Colorado

D & H Tamarac Research Center

Tamarac, Florida

Westmead Hospital

Westmead, New South Wales

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 6, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions